Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 29606586

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 May
First author
Laetsch TW

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 May;19(5):594-595. doi: 10.1016/S1470-2045(18)30191-8.
    note
    Source null
    related pmid
    29606584
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 May;19(5):e229. doi: 10.1016/S1470-2045(18)30286-9.
    note
    Source null
    related pmid
    29726388
    relationship
    Erratum in

Authors and identifiers

  1. name
    Laetsch TW
    type
    Author
  2. name
    DuBois SG
    type
    Author
  3. name
    Mascarenhas L
    type
    Author
  4. name
    Turpin B
    type
    Author
  5. name
    Federman N
    type
    Author
  6. name
    Albert CM
    type
    Author
  7. name
    Nagasubramanian R
    type
    Author
  8. name
    Davis JL
    type
    Author
  9. name
    Rudzinski E
    type
    Author
  10. name
    Feraco AM
    type
    Author
  11. name
    Tuch BB
    type
    Author
  12. name
    Ebata KT
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Laetsch TW
    type
    Author
  2. name
    DuBois SG
    type
    Author
  3. name
    Mascarenhas L
    type
    Author
  4. name
    Turpin B
    type
    Author
  5. name
    Federman N
    type
    Author
  6. name
    Albert CM
    type
    Author
  7. name
    Nagasubramanian R
    type
    Author
  8. name
    Davis JL
    type
    Author
  9. name
    Rudzinski E
    type
    Author
  10. name
    Feraco AM
    type
    Author
  11. name
    Tuch BB
    type
    Author
  12. name
    Ebata KT
    type
    Author
bibliography ids
  1. nci-bib-798bf29f0a0c5acd8c62e74b
book metadata
content sha256
7a8181ddd5c4a04253006b57ed6de11569dd06f37e148722c569b9f3f511ccb0
document type
citation
dois
  1. 10.1016/S1470-2045(18)30119-0
electronic publication date
display
2018 Mar 29
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29606586
immutable id
pubmed:29606586@7a8181ddd5c4a04253006b57ed6de11569dd06f37e148722c569b9f3f511ccb0
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
5
name
The Lancet. Oncology
nlm unique id
100957246
pages
705-714
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 May;19(5):594-595. doi: 10.1016/S1470-2045(18)30191-8.
    note
    Source null
    related pmid
    29606584
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 May;19(5):e229. doi: 10.1016/S1470-2045(18)30286-9.
    note
    Source null
    related pmid
    29726388
    relationship
    Erratum in
outcomes validated
false
pmid
29606586
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
70ba34506659647e0c379e222a7cd47e7858ad7453562ca96e4b2fea388ea356
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 May
precision
month
year
2018
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29606586/
title
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.

Preserved source evidence · Independent clinical review pending · Not medical advice